Total Holdings
44
Portfolio diversification across 44 positions
MEDI
(NYSEARCA)Harbor Health Care ETF
$33.38-- (--)
Loading... - Market loading
MEDI ETF Holdings: Harbor Health Care ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$42.25M
Total fund assets
Expense Ratio
0.80%
Annual management fee
Fund Issuer
Harbor
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 37 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Eli Lilly and Company | Stock | 21.34% |
| 2 |  | Ascendis Pharma A/S | Stock | 13.52% |
| 3 |  | Legend Biotech Corporation | Stock | 5.62% |
| 4 |  | Gilead Sciences, Inc. | Stock | 5.08% |
| 5 |  | Rhythm Pharmaceuticals, Inc. | Stock | 4.23% |
| 6 |  | AbbVie Inc | Stock | 3.61% |
| 7 |  | Intuitive Surgical, Inc | Stock | 3.42% |
| 8 | P PINK:AAVXF | ABIVAX Société Anonyme | Stock | 3.07% |
| 9 |  | Boston Scientific Corporation | Stock | 3.03% |
| 10 |  | Insmed Incorporated | Stock | 2.85% |
| 11 |  | Cencora, Inc. | Stock | 2.72% |
| 12 |  | Merck & Co., Inc. | Stock | 2.41% |
| 13 |  | Revolution Medicines, Inc. | Stock | 2.41% |
| 14 |  | Natera, Inc | Stock | 2.39% |
| 15 |  | ABIVAX Société Anonyme | Stock | 2.08% |
| 16 |  | argenx SE | Stock | 2.05% |
| 17 |  | Insulet Corporation | Stock | 2.05% |
| 18 |  | McKesson Corporation | Stock | 2.03% |
| 19 |  | Vaxcyte, Inc. | Stock | 2.01% |
| 20 |  | Danaher Corporation | Stock | 1.94% |
| 21 |  | UnitedHealth Group Incorporated | Stock | 1.77% |
| 22 |  | IDEXX Laboratories, Inc | Stock | 1.74% |
| 23 |  | Guardant Health, Inc | Stock | 1.72% |
| 24 |  | Vertex Pharmaceuticals Incorporated | Stock | 1.66% |
| 25 |  | Adaptive Biotechnologies Corporation | Stock | 1.34% |
| 26 |  | Novo Nordisk A/S | Stock | 1.28% |
| 27 |  | PTC Therapeutics, Inc | Stock | 1.27% |
| 28 |  | Alnylam Pharmaceuticals, Inc | Stock | 0.97% |
| 29 |  | Madrigal Pharmaceuticals, Inc | Stock | 0.79% |
| 30 |  | RadNet Inc | Stock | 0.75% |
| 31 |  | DexCom, Inc | Stock | 0.75% |
| 32 |  | Ionis Pharmaceuticals, Inc | Stock | 0.55% |
| 33 |  | Relay Therapeutics, Inc | Stock | 0.50% |
| 34 |  | Xenon Pharmaceuticals Inc | Stock | 0.44% |
| 35 |  | Oruka Therapeutics, Inc. | Stock | 0.44% |
| 36 |  | iRhythm Technologies, Inc | Stock | 0.37% |
| 37 |  | Sophia Genetics SA | Stock | 0.32% |
Frequently Asked Questions About Harbor Health Care ETF Holdings
What are the top holdings in MEDI?
Harbor Health Care ETF (MEDI) holds 44 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is MEDI's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review MEDI's holdings table to analyze concentration risk.
What is MEDI's sector allocation?
The Sector Allocation chart shows how MEDI distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does MEDI invest in?
MEDI's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is MEDI ETF?
MEDI's diversification can be assessed by reviewing its 44 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.